(2S,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate hydrochloride (1:1)(CAS: 33286-22-5)

This compound is a benzothiazepine derivative with a dimethylaminoethyl, methoxyphenyl, and acetyl group. It exists as a hydrochloride salt (1:1) and is characterized by its chiral centers (2S,3S) and molecular structure, making it relevant in pharmaceutical research for its potential biological activity and stability in aqueous solutions.

This compound is primarily used in pharmaceutical research as an intermediate for drug development, particularly in the synthesis of analgesics and sedatives. Its unique structure may also find applications in medicinal chemistry for targeting specific receptors, though specific commercial uses are not widely documented.

Safety depends on handling protocols. As a hydrochloride salt, it may exhibit irritant properties. Always use appropriate PPE, avoid inhalation or skin contact, and follow OSHA and GHS guidelines. Consult safety data sheets for detailed toxicity information and proper disposal methods.

Store in a sealed, cool (2-8°C), dry, and light-protected container. Keep away from moisture and incompatible substances. Ensure stability by maintaining controlled humidity levels and avoiding exposure to air to prevent degradation of its active chemical components.